Technical Analysis for EDAP - EDAP TMS S.A.

Grade Last Price % Change Price Change
grade B 4.52 1.57% 0.07
EDAP closed up 1.57 percent on Friday, September 20, 2019, on 1.96 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical EDAP trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup 1.57%
Upper Bollinger Band Walk Strength 1.57%
Pocket Pivot Bullish Swing Setup 2.49%

Older signals for EDAP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division offers medical devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. This division provides Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. It markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division provides medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division manufactures lithotripters, including the Sonolith i-move and the Sonolith i-sys, for the treatment of urinary tract stones by means of ESWL technology. It is also involved in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company's customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.
Medicine Health Medical Specialties Maintenance Services Prostate Cancer Ultrasound Magnetic Resonance Imaging Urology Medical Ultrasonography High Intensity Focused Ultrasound Localized Tumors Treatment Of Urological Diseases Urological Diseases
Is EDAP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.42
52 Week Low 1.35
Average Volume 198,446
200-Day Moving Average 3.1587
50-Day Moving Average 3.2907
20-Day Moving Average 3.7262
10-Day Moving Average 4.108
Average True Range 0.3043
ADX 58.54
+DI 31.0887
-DI 2.7752
Chandelier Exit (Long, 3 ATRs ) 3.8371
Chandelier Exit (Short, 3 ATRs ) 4.0229
Upper Bollinger Band 4.6306
Lower Bollinger Band 2.8218
Percent B (%b) 0.94
BandWidth 48.542751
MACD Line 0.3314
MACD Signal Line 0.2544
MACD Histogram 0.077
Fundamentals Value
Market Cap 131.06 Million
Num Shares 29 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 2.00
Price-to-Book 2.88
PEG Ratio 86.70
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.11
Resistance 3 (R3) 5.12 4.93 5.01
Resistance 2 (R2) 4.93 4.78 4.93 4.97
Resistance 1 (R1) 4.73 4.69 4.83 4.72 4.94
Pivot Point 4.54 4.54 4.60 4.54 4.54
Support 1 (S1) 4.34 4.39 4.44 4.33 4.10
Support 2 (S2) 4.15 4.30 4.15 4.07
Support 3 (S3) 3.95 4.15 4.03
Support 4 (S4) 3.94